How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.

Couto, J Pinto

How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer. [electronic resource] - Journal of clinical pathology May 2009 - 414-21 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1472-4146

10.1136/jcp.2008.055343 doi


Adenocarcinoma, Follicular--drug therapy
Antineoplastic Agents--therapeutic use
Carcinoma, Papillary--drug therapy
DNA, Mitochondrial--genetics
Gene Rearrangement
Humans
Mutation
Proto-Oncogene Proteins B-raf--genetics
Proto-Oncogene Proteins c-ret--genetics
Thyroid Neoplasms--drug therapy
ras Proteins--genetics